Wordt geladen...
Recent advances in the molecular understanding of glioblastoma
Glioblastoma is the most common and most aggressive primary brain tumor. Despite maximum treatment, patients only have a median survival time of 15 months, because of the tumor’s resistance to current therapeutic approaches. Thus far, methylation of the O (6)-methylguanine-DNA methyltransferase (MGM...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer US
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3337398/ https://ncbi.nlm.nih.gov/pubmed/22270850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-011-0793-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|